Search results
Author(s):
Derek P Chew
,
Harvey D White
Added:
3 years ago
Effective translation of reperfusion therapy to mortality reductions in ST-segment elevation myocardial infarction (STEMI) remains both time-critical in its implementation and dependent on optimal antithrombotic therapy. Innumerable clinical studies have explored several antithrombin and antiplatelet therapies in the immediate management of STEMI. With the wide array of the therapies now…
View more
Author(s):
Robert A Byrne
Added:
7 months ago
ESC 2023 — Dr Robert Byrne (Mater Private Hospital, Dublin, IE) joins us on-site to discuss the new guidelines from the ESC covering the management of acute coronary syndromes.
Acute Coronary Syndrome (ACS) is a broad spectrum of conditions, and the presentation can vary from a stable patient, to a patient who is critically ill. In the past, separate guidelines were issued for ST-Elevation…
View more
Author(s):
Masahiro Natsuaki
Added:
7 months ago
ESC 23 — Dr Masahiro Natsuaki (Saga University, JP) discusses the short and optimal duration of dual antiplatelet therapy-3 Study (STOPDAPT-3) (NCT04609111).
In the STOPDAPT-2 study, 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy was shown to provide benefits in bleeding reduction over a 12-month period, however, other trials have shown high rates of bleeding at…
View more
Author(s):
Philip J Devereaux
,
John Eikelboom
Added:
6 years ago
The effect of dabigatran in patients suffering myocardial injury after non-cardiac surgery - ACC 2018
An expert peer-to-peer discussion on the latest data to come out of the MANAGE trial and its implications for clinical practice.
Sunday 11th March 2018 @ 11:45 EST
ACC.18 Congress, Orlando, FL
Discussants: Dr PJ Devereaux (Ontario, US) & Dr John Eikelboom (Ontario, US)
Dr PJ…
View more
The MANAGE Study
Broadcast
Author(s):
Mirvat Alasnag
Added:
1 year ago
In this short and practice focused review, Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, SA) highlights some of the late-breaking clinical trials presented atACC.22from an interventionalist perspective.
Trials covered in detail include:
00:58: SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure
01:46: GHATI: Improving STEMI Management Internationally: Two…
View more
Author(s):
Hisham A Badreldin
,
Khalid bin Saleh
,
Majed Al-Yami
Added:
3 years ago
WRAP-IT
The Worldwide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT) was a prospective multicenter study to determine the safety and efficacy of an absorbable surgical mesh envelope containing two antibiotics (minocycline and rifampin) in reducing infection incidence in patients with cardiac implantable electronic devices compared to standard care.1 Approximately 7,000…
View more
View from the Thoraxcenter: ESC 23 Wrap Up
Video Series
Spontaneous Coronary Artery Dissection
Author(s):
Jacqueline Saw
Start date:
Jul 24, 2015
Broadcast
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022.
Trials covered in detail include:
00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients…
View more